ANTIBODY DRUG CONJUGATE SUMMIT
This innovative B2B event will enable the participants to learn about protein modeling development and engineering advances, preclinical and clinical improvements, current ADC linker chemistry- better linker design for future generations, improving preclinical and clinical translation and creating strong and scalable processes.
It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Lisbon!
Who Should attend:
CEOs, Directors, Heads & Managers Of Leading Application Creators & Suppliers